Metformin Hydrochloride Strides Pharma Uk

Metformin Hydrochloride, the active ingredient in Metformin Hydrochloride Strides Pharma Uk, is a biguanide presented as an oral tablet for oral use. It is used to improve blood glucose control in adults with type 2 diabetes mellitus. GNH USA supplies Metformin Hydrochloride Strides Pharma Uk as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metformin Hydrochloride is a biguanide that acts on glucose metabolism to manage several hyperglycaemic conditions. - Type 2 diabetes mellitus: improves glycaemic control by lowering fasting and post‑prandial glucose levels. - Prediabetes (impaired fasting glucose): helps reduce the risk of progression to overt diabetes. - Gestational diabetes (when insulin is not suitable): assists in maintaining maternal blood glucose within target ranges.

Metformin Hydrochloride is associated with several adverse reactions that vary in frequency.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhoea: frequent loose stools, especially at treatment initiation. - Abdominal discomfort: cramping or pain. - Metallic taste: transient alteration of taste perception. - Loss of appetite: reduced desire to eat. - Weight loss: modest reduction in body weight.

Serious or Rare Side Effects: - Lactic acidosis: rare but potentially fatal metabolic acidosis. - Severe skin reactions: such as Stevens‑Johnson syndrome. - Hepatotoxicity: liver enzyme elevations or injury. - Vitamin B12 deficiency: may develop with long‑term therapy. - Hypoglycaemia: uncommon unless combined with other glucose‑lowering agents. - Pancreatitis: rare inflammation of the pancreas.

Metformin Hydrochloride requires careful assessment before and during therapy. - Renal function: evaluate eGFR before initiation and periodically thereafter. - Hepatic impairment: use with caution in patients with liver disease. - Lactic acidosis risk: avoid in conditions causing hypoxia or severe infection. - Alcohol consumption: limit intake to reduce acidosis risk. - Pregnancy and lactation: assess risk‑benefit; use only if clearly needed. - Store at ambient temperature: keep in original container, protect from moisture and heat.

Metformin Hydrochloride can interact with several medicines, influencing its safety and efficacy.

Major Interactions (Avoid): - Iodinated contrast agents: may precipitate acute kidney injury. - Cimetidine: can increase metformin plasma concentrations. - Nucleoside reverse transcriptase inhibitors: raise risk of lactic acidosis.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask symptoms of hypoglycaemia. - Diuretics: affect renal clearance of metformin. - ACE inhibitors or ARBs: require monitoring of renal function and electrolytes.